halofuginone inhibits th17 cell differentiation activating amino acid starvation response 
central challenge improving autoimmune therapy preventing inflammatory pathology without inducing generalized immunosuppression t helper th17 cells characterized production interleukin- emerged important broad mediators autoimmunity show small molecule halofuginone hf selectively inhibits mouse human th17 differentiation activating cytoprotective signaling pathway amino acid starvation response aar inhibition th17 differentiation hf rescued addition excess amino acids mimicked aar activation selective amino acid depletion hf also induces aar vivo protects mice th17-associated experimental autoimmune encephalomyelitis results indicate aar pathway potent selective regulator inflammatory t cell differentiation vivo 
